Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Unfit Patients”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)UnknownNCT04254640
What this trial is testing

Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML

Who this might be right for
Acute Myeloid LeukemiaElderly PatientsNewly Diagnosed
Sun Yat-sen University 34
Testing effectiveness (Phase 2)Looking for participantsNCT06387121
What this trial is testing

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 53
Testing effectiveness (Phase 2)UnknownNCT03949062
What this trial is testing

Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04824924
What this trial is testing

Venetoclax in Combination With Low-dose HHT, G-CSF, and AZA as First-line Treatment for Newly Diagnosed Elderly AML Patients Unfit for Intensive Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT01444716
What this trial is testing

Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT01810705
What this trial is testing

GRASPA Treatment for Patients With Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloid Leukemia
ERYtech Pharma 123
Testing effectiveness (Phase 2)UnknownNCT01488344
What this trial is testing

Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
University Hospital Muenster 140
Early research (Phase 1)UnknownNCT00636922
What this trial is testing

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Bayside Health 40
Large-scale testing (Phase 3)UnknownNCT04490707
What this trial is testing

Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

Who this might be right for
Acute Myeloid Leukemia in Remission
Ge Zheng 60
Testing effectiveness (Phase 2)Study completedNCT01576588
What this trial is testing

Rituximab in Pretreated Elderly or Unfit B-CLL Patients

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Prof. Dr. Med. Laimonas Griskevicius 25
Testing effectiveness (Phase 2)Looking for participantsNCT06656598
What this trial is testing

Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

Who this might be right for
Stage III NSCLC
Intergroupe Francophone de Cancerologie Thoracique 152
Testing effectiveness (Phase 2)Looking for participantsNCT07205731
What this trial is testing

Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
University Hospital, Clermont-Ferrand 95
Testing effectiveness (Phase 2)UnknownNCT03809780
What this trial is testing

Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
Kosin University Gospel Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01025505
What this trial is testing

Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study

Who this might be right for
TreatmentStem Cell Transplantation
Gruppo Italiano Malattie EMatologiche dell'Adulto 40
Not applicableUnknownNCT01862445
What this trial is testing

Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients

Who this might be right for
CLLB-cellSmall Lymphocytic Lymphoma+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 100
Testing effectiveness (Phase 2)Ended earlyNCT02495454
What this trial is testing

GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma

Who this might be right for
CD20 Positive Diffuse Large B-cell LymphomaElderly Unfit Patients
Fondazione Italiana Linfomi - ETS 34
Testing effectiveness (Phase 2)Study completedNCT02015208
What this trial is testing

Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Sunnybrook Health Sciences Centre 13
Not applicableNot Yet RecruitingNCT07476105
What this trial is testing

Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment

Who this might be right for
Diffuse Large B Cell LymphomaFollicular Lymphoma Grade 3B
Fondazione Italiana Linfomi - ETS 170
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07207785
What this trial is testing

PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Fondazione Italiana Linfomi - ETS 56
Large-scale testing (Phase 3)Study completedNCT01884623
What this trial is testing

Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head Neck Cancer Squamous Cell Recurrent
Gustave Roussy, Cancer Campus, Grand Paris 82
Load More Results